Impact of Fruit and Vegetables in PKU

NCT ID: NCT05249218

Last Updated: 2022-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-20

Study Completion Date

2021-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the UK, some fruits and vegetables are permitted without measurement in the diets of people with phenylketonuria (PKU). It is proven that fruits and vegetables containing phenylalanine (Phe) up to 75mg/100g (e.g. carrots, sweet potato, tomatoes) do not affect blood Phe control but it is unknown to what extent fruits and vegetables containing Phe from 76-100mg/100g (e.g. cauliflower, broccoli, beansprouts and asparagus) increase blood Phe levels. In addition, there is very little information about how differently animal and vegetable protein affect blood Phe levels. It is believed that plant protein may have less bioavailability and therefore have less impact on blood Phe control. The investigators aim is to perform a randomized controlled study over 21 weeks in children (5-12y) with PKU. Children will be studied during five different time periods, examining the effect on blood Phe control when increasing Phe intake from vegetables/fruits containing Phe from 76-100 mg/100g vs. animal sources. At the end of the study, fruits and vegetables containing 76- 100mg Phe/100g will continue to be given as "exchange-free" for 6 months. This is a practical, cost effective study and should bring benefit to all people with PKU following a very restrictive diet both within the UK and throughout the world.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Phenylketonurias

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This is a prospective, randomised controlled study over 21 weeks in children to assess how Phe intake from fruits and vegetables (containing 76-100 mg Phe/100g) vs. animal sources will impact on blood Phe control. This will be followed by a 6 months extension study examining the 'unlimited' use of fruits and vegetables containing Phe 76-100 mg/100g on blood Phe control.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group starting intervention with vegetable protein

Phase A followed by Phases B, C, D, E.

Group Type ACTIVE_COMPARATOR

Phase B - Extra 1 Phe exchange from fruits/vegetables containing Phe from 76-100mg/100g

Intervention Type OTHER

Usual low Phe diet + 60g fruits/vegetables containing Phe from 76-100mg/100g

Phase C - Extra 2 Phe exchanges from fruits/vegetables containing Phe from 76-100mg/100g

Intervention Type OTHER

Usual low Phe diet + 120g fruits/vegetables containing Phe from 76-100mg/100g

Phase D - Extra 1 Phe exchange from milk or yoghurt

Intervention Type OTHER

Usual low Phe diet but 1 x 50 mg extra Phe exchange from milk or yoghurt

Phase E - Extra 2 Phe exchanges from milk or yoghurt

Intervention Type OTHER

Usual low Phe diet but 2 x 50 mg extra Phe exchange from milk or yoghurt eaten daily

Group starting intervention with animal protein

Phase A followed by Phases D, E, B, C.

Group Type ACTIVE_COMPARATOR

Phase B - Extra 1 Phe exchange from fruits/vegetables containing Phe from 76-100mg/100g

Intervention Type OTHER

Usual low Phe diet + 60g fruits/vegetables containing Phe from 76-100mg/100g

Phase C - Extra 2 Phe exchanges from fruits/vegetables containing Phe from 76-100mg/100g

Intervention Type OTHER

Usual low Phe diet + 120g fruits/vegetables containing Phe from 76-100mg/100g

Phase D - Extra 1 Phe exchange from milk or yoghurt

Intervention Type OTHER

Usual low Phe diet but 1 x 50 mg extra Phe exchange from milk or yoghurt

Phase E - Extra 2 Phe exchanges from milk or yoghurt

Intervention Type OTHER

Usual low Phe diet but 2 x 50 mg extra Phe exchange from milk or yoghurt eaten daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phase B - Extra 1 Phe exchange from fruits/vegetables containing Phe from 76-100mg/100g

Usual low Phe diet + 60g fruits/vegetables containing Phe from 76-100mg/100g

Intervention Type OTHER

Phase C - Extra 2 Phe exchanges from fruits/vegetables containing Phe from 76-100mg/100g

Usual low Phe diet + 120g fruits/vegetables containing Phe from 76-100mg/100g

Intervention Type OTHER

Phase D - Extra 1 Phe exchange from milk or yoghurt

Usual low Phe diet but 1 x 50 mg extra Phe exchange from milk or yoghurt

Intervention Type OTHER

Phase E - Extra 2 Phe exchanges from milk or yoghurt

Usual low Phe diet but 2 x 50 mg extra Phe exchange from milk or yoghurt eaten daily

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PKU patients diagnosed by NBS and BH4 deficiencies;
* Early and continuously treated;
* Adherent to their prescribed PKU diet consisting of a protein-restricted diet and Phe-free amino acid based protein substitute;
* In good general health as evidenced by medical history;
* Able to provide written informed consent/assent (parent/child);
* Able to comply with the study protocol and take study product according to the opinion of the PI;
* Patients with good metabolic control (age 5-12y, 120-360μmol/L) with 3 out of 4 levels within range prior to consent (if 2 of 4 above target range but one close to the upper limit, PI to decide if patient can enter the study).

Exclusion Criteria

* Concomitant diseases / disorders such as renal or gut disease / disorders and diabetes;
* Dislikes fruits and vegetables containing 76-100 mg of Phe/100g e.g.brocolli or cauliflower;
* Treated with BH4 (sapropterin);
* Presence of intercurrent infection;
* Patients with poor metabolic control (age 5-12y, \>360μmol/L).
Minimum Eligible Age

5 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alex Pinto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alex Pinto

Research Dietitian

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Birmingham Women's and Children's Hospital

Birmingham, West Midlands, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18/BC/DTS/NO/215

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.